TVTX vs. RIGL
TVTX (Travere Therapeutics, Inc.) and RIGL (Rigel Pharmaceuticals, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, TVTX returned 10.47%/yr vs 2.33%/yr for RIGL. At a 0.36 correlation, their price movements are largely independent.
Performance
TVTX vs. RIGL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TVTX achieves a 23.21% return, which is significantly higher than RIGL's -29.77% return. Over the past 10 years, TVTX has outperformed RIGL with an annualized return of 10.47%, while RIGL has yielded a comparatively lower 2.33% annualized return.
TVTX
- 1D
- 2.77%
- 1M
- 10.52%
- YTD
- 23.21%
- 6M
- 37.30%
- 1Y
- 207.31%
- 3Y*
- 41.35%
- 5Y*
- 25.91%
- 10Y*
- 10.47%
RIGL
- 1D
- 0.50%
- 1M
- 15.51%
- YTD
- -29.77%
- 6M
- -30.69%
- 1Y
- 39.97%
- 3Y*
- 23.16%
- 5Y*
- -5.96%
- 10Y*
- 2.33%
TVTX vs. RIGL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TVTX Travere Therapeutics, Inc. | 23.21% | 119.35% | 93.77% | -57.25% | -32.25% | 13.89% | 91.94% | -37.25% | 7.40% | 11.30% |
RIGL Rigel Pharmaceuticals, Inc. | -29.77% | 154.64% | 16.00% | -3.33% | -43.40% | -24.29% | 63.55% | -6.96% | -40.72% | 63.03% |
Correlation
The correlation between TVTX and RIGL is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.34 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.35 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.39 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.38 |
Correlation (All Time) Calculated using the full available price history since Nov 8, 2012 | 0.36 |
Fundamentals
TVTX:
$4.33B
RIGL:
$592.15M
TVTX:
-$0.49
RIGL:
$19.21
TVTX:
8.20
RIGL:
1.90
TVTX:
43.81
RIGL:
1.48
TVTX:
$536.20M
RIGL:
$299.77M
TVTX:
$385.20M
RIGL:
$279.95M
TVTX:
$11.15M
RIGL:
$125.80M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TVTX vs. RIGL — Risk / Return Rank
TVTX
RIGL
TVTX vs. RIGL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Travere Therapeutics, Inc. (TVTX) and Rigel Pharmaceuticals, Inc. (RIGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| TVTX | RIGL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.34 | ||
| Sortino ratioReturn per unit of downside risk | +2.46 | ||
| Omega ratioGain probability vs. loss probability | 1.48 | 1.17 | +0.31 |
| Calmar ratioReturn relative to maximum drawdown | 6.23 | 0.80 | +5.43 |
| Martin ratioReturn relative to average drawdown | 14.39 | 1.41 | +12.98 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| TVTX | RIGL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.92 | 0.58 | +2.34 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.39 | -0.07 | +0.46 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.18 | 0.03 | +0.15 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.30 | -0.13 | +0.42 |
Drawdowns
TVTX vs. RIGL - Drawdown Comparison
The maximum TVTX drawdown since its inception was -85.43%, smaller than the maximum RIGL drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for TVTX and RIGL.
Loading charts...
Drawdown Indicators
| TVTX | RIGL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -85.43% | -99.37% | +13.94% |
Max Drawdown (1Y)Largest decline over 1 year | -33.49% | -50.08% | +16.59% |
Max Drawdown (3Y)Largest decline over 3 years | -69.77% | -57.75% | -12.02% |
Max Drawdown (5Y)Largest decline over 5 years | -83.12% | -85.24% | +2.12% |
Max Drawdown (10Y)Largest decline over 10 years | -83.64% | -86.40% | +2.76% |
Current DrawdownCurrent decline from peak | -1.42% | -97.18% | +95.76% |
Average DrawdownAverage peak-to-trough decline | -41.13% | -90.92% | +49.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.49% | 28.34% | -13.85% |
Volatility
TVTX vs. RIGL - Volatility Comparison
The current volatility for Travere Therapeutics, Inc. (TVTX) is 14.17%, while Rigel Pharmaceuticals, Inc. (RIGL) has a volatility of 18.26%. This indicates that TVTX experiences smaller price fluctuations and is considered to be less risky than RIGL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TVTX | RIGL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.17% | 18.26% | -4.09% |
Volatility (6M)Calculated over the trailing 6-month period | 51.90% | 38.39% | +13.51% |
Volatility (1Y)Calculated over the trailing 1-year period | 71.68% | 69.94% | +1.74% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 66.44% | 85.50% | -19.06% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 58.34% | 82.83% | -24.49% |
Dividends
TVTX vs. RIGL - Dividend Comparison
Neither TVTX nor RIGL has paid dividends to shareholders.
Financials
TVTX vs. RIGL - Financials Comparison
This section allows you to compare key financial metrics between Travere Therapeutics, Inc. and Rigel Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TVTX vs. RIGL - Profitability Comparison
TVTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Travere Therapeutics, Inc. reported a gross profit of 0.00 and revenue of 127.20M. Therefore, the gross margin over that period was 0.0%.
RIGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a gross profit of 54.21M and revenue of 58.82M. Therefore, the gross margin over that period was 92.2%.
TVTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Travere Therapeutics, Inc. reported an operating income of -36.60M and revenue of 127.20M, resulting in an operating margin of -28.8%.
RIGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported an operating income of 11.89M and revenue of 58.82M, resulting in an operating margin of 20.2%.
TVTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Travere Therapeutics, Inc. reported a net income of -37.10M and revenue of 127.20M, resulting in a net margin of -29.2%.
RIGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a net income of 8.65M and revenue of 58.82M, resulting in a net margin of 14.7%.
Frequently Asked Questions
TVTX and RIGL have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RIGL has higher volatility (18.26%) compared to TVTX (14.17%). In terms of maximum drawdown, TVTX dropped -85.43% vs RIGL's -99.37%.
TVTX currently has the higher Sharpe Ratio (2.92 vs 0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TVTX and RIGL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer